Iveena Delivery Systems

Ophthalmology company developing disease-modifying eye drops for keratoconus and myopia

placeSalt Lake City, Utah, United States calendar_todayFounded 2012 groups6 employees language iveenamed.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 16 times.

YearFilings
20191
20221
20231
20241
20251

Social engagement

Social engagement: 575 social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Angel & family office125%
Other / undisclosed250%

Recent activity

11 Feb 2026
Milestone
regulatory
Coming soon